Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 105.15 $ -2.99 (-2.76%)
Last Price 105.15 Change $ -2.99 Change % -2.76 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 105.14 High 105.53 Low 105.14 Prev Close 108.14
Last Trade Volume 701 52 Wk Hi 114.01 52 Wk Low 74.51
Market Cap 12.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 122,078,944.00 EPS (TTM) 1.57 PE Ratio 67.10 Exchange OTCPK